


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Clinical Medicine Notes">
      
      
        <link rel="canonical" href="http://localhost:8000/frontiers/">
      
      
        <meta name="author" content="Jingzhi An">
      
      <link rel="shortcut icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.1, mkdocs-material-5.0.0rc4">
    
    
      
        <title>Frontiers - Clinical Medicine Notes</title>
      
    
    
      <link rel="stylesheet" href="../assets/stylesheets/main.c1451e9e.min.css">
      
        <link rel="stylesheet" href="../assets/stylesheets/palette.4444686e.min.css">
      
      
        
        
        <meta name="theme-color" content="#3f51b5">
      
    
    
    
      
        <link href="https://fonts.gstatic.com" rel="preconnect" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,400,400i,700%7CRoboto+Mono&display=fallback">
        <style>body,input{font-family:"Roboto",-apple-system,BlinkMacSystemFont,Helvetica,Arial,sans-serif}code,kbd,pre{font-family:"Roboto Mono",SFMono-Regular,Consolas,Menlo,monospace}</style>
      
    
    
    
    
      
    
    
  </head>
  
  
    
    
    <body dir="ltr" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#frontiers-in-medicine" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
      <header class="md-header" data-md-component="header">
  <nav class="md-header-nav md-grid" aria-label="Header">
    <a href="http://localhost:8000" title="Clinical Medicine Notes" class="md-header-nav__button md-logo" aria-label="Clinical Medicine Notes">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12,8A3,3 0 0,0 15,5A3,3 0 0,0 12,2A3,3 0 0,0 9,5A3,3 0 0,0 12,8M12,11.54C9.64,9.35 6.5,8 3,8V19C6.5,19 9.64,20.35 12,22.54C14.36,20.35 17.5,19 21,19V8C17.5,8 14.36,9.35 12,11.54Z" /></svg>

    </a>
    <label class="md-header-nav__button md-icon" for="__drawer">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3,6H21V8H3V6M3,11H21V13H3V11M3,16H21V18H3V16Z" /></svg>
    </label>
    <div class="md-header-nav__title" data-md-component="header-title">
      
        <div class="md-header-nav__ellipsis">
          <span class="md-header-nav__topic md-ellipsis">
            Clinical Medicine Notes
          </span>
          <span class="md-header-nav__topic md-ellipsis">
            
              Frontiers
            
          </span>
        </div>
      
    </div>
    
      <label class="md-header-nav__button md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5,3A6.5,6.5 0 0,1 16,9.5C16,11.11 15.41,12.59 14.44,13.73L14.71,14H15.5L20.5,19L19,20.5L14,15.5V14.71L13.73,14.44C12.59,15.41 11.11,16 9.5,16A6.5,6.5 0 0,1 3,9.5A6.5,6.5 0 0,1 9.5,3M9.5,5C7,5 5,7 5,9.5C5,12 7,14 9.5,14C12,14 14,12 14,9.5C14,7 12,5 9.5,5Z" /></svg>
      </label>
      
<div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" data-md-state="active">
      <label class="md-search__icon md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5,3A6.5,6.5 0 0,1 16,9.5C16,11.11 15.41,12.59 14.44,13.73L14.71,14H15.5L20.5,19L19,20.5L14,15.5V14.71L13.73,14.44C12.59,15.41 11.11,16 9.5,16A6.5,6.5 0 0,1 3,9.5A6.5,6.5 0 0,1 9.5,3M9.5,5C7,5 5,7 5,9.5C5,12 7,14 9.5,14C12,14 14,12 14,9.5C14,7 12,5 9.5,5Z" /></svg>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20,11V13H8L13.5,18.5L12.08,19.92L4.16,12L12.08,4.08L13.5,5.5L8,11H20Z" /></svg>
      </label>
      <button type="reset" class="md-search__icon md-icon" aria-label="Clear" data-md-component="search-reset" tabindex="-1">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19,6.41L17.59,5L12,10.59L6.41,5L5,6.41L10.59,12L5,17.59L6.41,19L12,13.41L17.59,19L19,17.59L13.41,12L19,6.41Z" /></svg>
      </button>
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Type to start searching
          </div>
          <ol class="md-search-result__list"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header-nav__source">
        
<a href="https://github.com/jingzhian/mkdocs-md-notes/" title="Go to repository" class="md-source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path d="M439.55 236.05L244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81z"/></svg>
  </div>
  <div class="md-source__repository">
    jingzhian/mkdocs-md-notes
  </div>
</a>
      </div>
    
  </nav>
</header>
    
    <div class="md-container" data-md-component="container">
      
        
      
      
        
          

<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-tabs__inner md-grid">
    <ul class="md-tabs__list">
      
        
  <li class="md-tabs__item">
    
      <a href=".." class="md-tabs__link md-tabs__link--active">
        Home
      </a>
    
  </li>

      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
    </ul>
  </div>
</nav>
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              <div class="md-sidebar md-sidebar--primary" data-md-component="navigation">
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    <nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="http://localhost:8000" title="Clinical Medicine Notes" class="md-nav__button md-logo" aria-label="Clinical Medicine Notes">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12,8A3,3 0 0,0 15,5A3,3 0 0,0 12,2A3,3 0 0,0 9,5A3,3 0 0,0 12,8M12,11.54C9.64,9.35 6.5,8 3,8V19C6.5,19 9.64,20.35 12,22.54C14.36,20.35 17.5,19 21,19V8C17.5,8 14.36,9.35 12,11.54Z" /></svg>

    </a>
    Clinical Medicine Notes
  </label>
  
    <div class="md-nav__source">
      
<a href="https://github.com/jingzhian/mkdocs-md-notes/" title="Go to repository" class="md-source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path d="M439.55 236.05L244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81z"/></svg>
  </div>
  <div class="md-source__repository">
    jingzhian/mkdocs-md-notes
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
      


  <li class="md-nav__item">
    <a href=".." title="Home" class="md-nav__link">
      Home
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../exam-info/" title="Exam Info" class="md-nav__link">
      Exam Info
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../healthcare-system/" title="Healthcare System" class="md-nav__link">
      Healthcare System
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../biomed-sciences/" title="Basics of Anatomy, Physiology & Pathology" class="md-nav__link">
      Basics of Anatomy, Physiology & Pathology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../clinic-foundation/" title="Foundation of Clinical Medicine" class="md-nav__link">
      Foundation of Clinical Medicine
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../encounter/" title="Bedside Etiquette" class="md-nav__link">
      Bedside Etiquette
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../approach/" title="Common presentations" class="md-nav__link">
      Common presentations
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../emergency/" title="Emergency" class="md-nav__link">
      Emergency
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../opthalmology.md" title="None" class="md-nav__link">
      None
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../neurology/" title="Neurology" class="md-nav__link">
      Neurology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../endocrinology/" title="Endocrinology" class="md-nav__link">
      Endocrinology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../cardiovascular/" title="Cardiovascular" class="md-nav__link">
      Cardiovascular
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../pulmonology/" title="Pulmonology" class="md-nav__link">
      Pulmonology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../gi/" title="Gi" class="md-nav__link">
      Gi
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../urorenal/" title="Urorenal" class="md-nav__link">
      Urorenal
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../obstetrics/" title="Obstetrics" class="md-nav__link">
      Obstetrics
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../hematology/" title="Hematology" class="md-nav__link">
      Hematology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../oncology/" title="Oncology" class="md-nav__link">
      Oncology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../msk/" title="Msk" class="md-nav__link">
      Msk
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../dermatology/" title="Dermatology" class="md-nav__link">
      Dermatology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../rheumatology/" title="Rheumatology" class="md-nav__link">
      Rheumatology
    </a>
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../psychiatry/" title="Psychiatry" class="md-nav__link">
      Psychiatry
    </a>
  </li>

    
      
      
      

  


  <li class="md-nav__item md-nav__item--active">
    
    <input class="md-nav__toggle md-toggle" data-md-toggle="toc" type="checkbox" id="__toc">
    
      
    
    
      <label class="md-nav__link md-nav__link--active" for="__toc">
        Frontiers
        <span class="md-nav__icon md-icon">
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3,9H17V7H3V9M3,13H17V11H3V13M3,17H17V15H3V17M19,17H21V15H19V17M19,7V9H21V7H19M19,13H21V11H19V13Z" /></svg>
        </span>
      </label>
    
    <a href="./" title="Frontiers" class="md-nav__link md-nav__link--active">
      Frontiers
    </a>
    
      
<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20,11V13H8L13.5,18.5L12.08,19.92L4.16,12L12.08,4.08L13.5,5.5L8,11H20Z" /></svg>
      </span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#clinical-medicine-developments" class="md-nav__link">
    Clinical Medicine Developments
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#industry-trends" class="md-nav__link">
    Industry Trends
  </a>
  
    <nav class="md-nav" aria-label="Industry Trends">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#trends-in-biotech" class="md-nav__link">
    Trends in biotech
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#research-meetings" class="md-nav__link">
    Research Meetings
  </a>
  
    <nav class="md-nav" aria-label="Research Meetings">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#md-phd-round-how-to-read-clinical-journals" class="md-nav__link">
    MD-PhD Round: How to Read Clinical Journals
  </a>
  
    <nav class="md-nav" aria-label="MD-PhD Round: How to Read Clinical Journals">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#when-to-start-clinical-trial" class="md-nav__link">
    When to start clinical trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#methods-of-randomization" class="md-nav__link">
    Methods of Randomization
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#outcome-design-of-clinical-trial" class="md-nav__link">
    Outcome Design of Clinical Trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#ways-of-analysing-a-rct-clinical-trial" class="md-nav__link">
    Ways of Analysing a RCT Clinical Trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#statistical-measures" class="md-nav__link">
    Statistical measures
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
          <li class="md-nav__item">
  <a href="#examining-covid19-through-a-multidimensional-lens" class="md-nav__link">
    Examining COVID19 - Through a Multidimensional Lens
  </a>
  
    <nav class="md-nav" aria-label="Examining COVID19 - Through a Multidimensional Lens">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#covid19-in-the-context-of-emerging-zoonoic-bat-viruses-in-a-quarter-of-century" class="md-nav__link">
    COVID19 in the context of emerging Zoonoic Bat Viruses in a Quarter of Century
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#exploring-the-use-of-modelling-to-evaluate-policy-response-to-covid19" class="md-nav__link">
    Exploring the Use of Modelling to Evaluate Policy Response to COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#deploying-digital-technology-for-covid19" class="md-nav__link">
    Deploying Digital Technology for COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#issues-in-coordinating-a-global-response" class="md-nav__link">
    Issues in Coordinating a Global Response
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#gauging-the-economics-and-market-implications-of-covid19" class="md-nav__link">
    Gauging the Economics and Market Implications of COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#converging-the-discourses-on-covid19" class="md-nav__link">
    Converging the Discourses on COVID19
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
          <li class="md-nav__item">
  <a href="#nsrl-p01-meetings-multi-scale-anesthesiology-reesarch" class="md-nav__link">
    NSRL P01 Meetings - Multi-scale Anesthesiology Reesarch
  </a>
  
    <nav class="md-nav" aria-label="NSRL P01 Meetings - Multi-scale Anesthesiology Reesarch">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#general" class="md-nav__link">
    General
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#human" class="md-nav__link">
    Human
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#non-human-primate" class="md-nav__link">
    Non-human Primate
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#rodents" class="md-nav__link">
    Rodents
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#modeling" class="md-nav__link">
    Modeling
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#data-core" class="md-nav__link">
    Data Core
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
    
  </li>

    
      
      
      


  <li class="md-nav__item">
    <a href="../temp-notes/" title="Temporary notes" class="md-nav__link">
      Temporary notes
    </a>
  </li>

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              <div class="md-sidebar md-sidebar--secondary" data-md-component="toc">
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    
<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20,11V13H8L13.5,18.5L12.08,19.92L4.16,12L12.08,4.08L13.5,5.5L8,11H20Z" /></svg>
      </span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#clinical-medicine-developments" class="md-nav__link">
    Clinical Medicine Developments
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#industry-trends" class="md-nav__link">
    Industry Trends
  </a>
  
    <nav class="md-nav" aria-label="Industry Trends">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#trends-in-biotech" class="md-nav__link">
    Trends in biotech
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#research-meetings" class="md-nav__link">
    Research Meetings
  </a>
  
    <nav class="md-nav" aria-label="Research Meetings">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#md-phd-round-how-to-read-clinical-journals" class="md-nav__link">
    MD-PhD Round: How to Read Clinical Journals
  </a>
  
    <nav class="md-nav" aria-label="MD-PhD Round: How to Read Clinical Journals">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#when-to-start-clinical-trial" class="md-nav__link">
    When to start clinical trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#methods-of-randomization" class="md-nav__link">
    Methods of Randomization
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#outcome-design-of-clinical-trial" class="md-nav__link">
    Outcome Design of Clinical Trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#ways-of-analysing-a-rct-clinical-trial" class="md-nav__link">
    Ways of Analysing a RCT Clinical Trial
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#statistical-measures" class="md-nav__link">
    Statistical measures
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
          <li class="md-nav__item">
  <a href="#examining-covid19-through-a-multidimensional-lens" class="md-nav__link">
    Examining COVID19 - Through a Multidimensional Lens
  </a>
  
    <nav class="md-nav" aria-label="Examining COVID19 - Through a Multidimensional Lens">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#covid19-in-the-context-of-emerging-zoonoic-bat-viruses-in-a-quarter-of-century" class="md-nav__link">
    COVID19 in the context of emerging Zoonoic Bat Viruses in a Quarter of Century
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#exploring-the-use-of-modelling-to-evaluate-policy-response-to-covid19" class="md-nav__link">
    Exploring the Use of Modelling to Evaluate Policy Response to COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#deploying-digital-technology-for-covid19" class="md-nav__link">
    Deploying Digital Technology for COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#issues-in-coordinating-a-global-response" class="md-nav__link">
    Issues in Coordinating a Global Response
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#gauging-the-economics-and-market-implications-of-covid19" class="md-nav__link">
    Gauging the Economics and Market Implications of COVID19
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#converging-the-discourses-on-covid19" class="md-nav__link">
    Converging the Discourses on COVID19
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
          <li class="md-nav__item">
  <a href="#nsrl-p01-meetings-multi-scale-anesthesiology-reesarch" class="md-nav__link">
    NSRL P01 Meetings - Multi-scale Anesthesiology Reesarch
  </a>
  
    <nav class="md-nav" aria-label="NSRL P01 Meetings - Multi-scale Anesthesiology Reesarch">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#general" class="md-nav__link">
    General
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#human" class="md-nav__link">
    Human
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#non-human-primate" class="md-nav__link">
    Non-human Primate
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#rodents" class="md-nav__link">
    Rodents
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#modeling" class="md-nav__link">
    Modeling
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#data-core" class="md-nav__link">
    Data Core
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          <div class="md-content">
            <article class="md-content__inner md-typeset">
              
                
                  <a href="https://github.com/jingzhian/mkdocs-md-notes/edit/master/docs/frontiers.md" title="Edit this page" class="md-content__button md-icon">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20.71,7.04C21.1,6.65 21.1,6 20.71,5.63L18.37,3.29C18,2.9 17.35,2.9 16.96,3.29L15.12,5.12L18.87,8.87M3,17.25V21H6.75L17.81,9.93L14.06,6.18L3,17.25Z" /></svg>
                  </a>
                
                
                  
                
                
                <h1 id="frontiers-in-medicine">Frontiers in Medicine<a class="headerlink" href="#frontiers-in-medicine" title="Permanent link">&para;</a></h1>
<h2 id="clinical-medicine-developments">Clinical Medicine Developments<a class="headerlink" href="#clinical-medicine-developments" title="Permanent link">&para;</a></h2>
<h2 id="industry-trends">Industry Trends<a class="headerlink" href="#industry-trends" title="Permanent link">&para;</a></h2>
<h3 id="trends-in-biotech">Trends in biotech<a class="headerlink" href="#trends-in-biotech" title="Permanent link">&para;</a></h3>
<ul>
<li>
<p>More approved drugs but with a shift from mass-market treatments to more specialist therapy areas</p>
<ul>
<li>
<p>In 2017, the U.S. Food and Drug Administration, gatekeeper to the world's biggest drugs market, has approved 41 novel drugs compared with 22 for the whole of 2016.</p>
</li>
<li>
<p>Average internal rate of return (IRR) down sharply from 10.1 percent in 2010 to 3.2 percent this year for 12 big pharma in Deloitte study including Pfizer, Roche, Novartis, Sanofi, GlaxoSmithKline, Johnson &amp; Johnson, AstraZeneca, Merck &amp; Co, Eli Lilly, Bristol-Myers Squibb, Takeda and Amgen</p>
</li>
</ul>
</li>
<li>
<p>More gene-modified cell therapy: Novartis' cell therapy Kymriah costing $ 475,000, while gene therapy could fetch around $1 million per patient.</p>
</li>
<li>
<p>Higher cost in drug development: Today, the average cost of bringing a new drug to market at a large company is nearly $2 billion, up from $1.2 billion in 2010, while forecast annual peak sales per drug have fallen from $816 million in 2010 to $465 million.</p>
</li>
</ul>
<p>Why is there an increase in cost and price?</p>
<ul>
<li>
<p>According to pharm: The high costs of their products are justified because the proceeds generate money for crucial research on new cures and treatments.</p>
</li>
<li>
<p>According to study: A social disease called maximizing shareholder value</p>
<p>Companies spend more on share buyback and dividends in a recent 10-year period than on R &amp; D. From 2006 through 2015, the 18 drug companies in the Standard &amp; Poor's 500 index spent a combined $516 billion on buybacks and dividends. This exceeded by 11 percent the companies' research and development spending of $465 billion during these years. The authors contend that many big pharmaceutical companies are living off patents that are decades-old and have little to show in the way of new blockbuster drugs. But their share buybacks and dividend payments inoculate them against shareholders who might be concerned about lackluster research and development.</p>
<ul>
<li>
<p>Gilead Sciences spent $27 billion on buybacks versus $17 billion on research</p>
</li>
<li>
<p>Biogen Idec repurchased $14.6 billion in stock and spent $13.8 billion on R&amp;D.</p>
</li>
</ul>
</li>
</ul>
<h2 id="research-meetings">Research Meetings<a class="headerlink" href="#research-meetings" title="Permanent link">&para;</a></h2>
<h3 id="md-phd-round-how-to-read-clinical-journals">MD-PhD Round: How to Read Clinical Journals<a class="headerlink" href="#md-phd-round-how-to-read-clinical-journals" title="Permanent link">&para;</a></h3>
<p><img alt="Approach tor reading clinical papers by Sacketts et al in 1981" src="../figures/approach-readpapers.png" />{#fig:approach-readpaper width="\textwidth"}</p>
<h4 id="when-to-start-clinical-trial">When to start clinical trial<a class="headerlink" href="#when-to-start-clinical-trial" title="Permanent link">&para;</a></h4>
<ul>
<li>
<p>Available</p>
</li>
<li>
<p>Accessible</p>
</li>
<li>
<p>Affordable</p>
</li>
<li>
<p>Acceptable</p>
</li>
</ul>
<h4 id="methods-of-randomization">Methods of Randomization<a class="headerlink" href="#methods-of-randomization" title="Permanent link">&para;</a></h4>
<p>Problems with randomization</p>
<ul>
<li>
<p>Assign patients in turn to control or placebo group</p>
</li>
<li>
<p>Assign patients in one clinic to one arm and the other to another</p>
</li>
</ul>
<h4 id="outcome-design-of-clinical-trial">Outcome Design of Clinical Trial<a class="headerlink" href="#outcome-design-of-clinical-trial" title="Permanent link">&para;</a></h4>
<ul>
<li>
<p>Composite Measures</p>
<ul>
<li>
<p>Look at all possible outcomes</p>
</li>
<li>
<p>Example: time to first event</p>
</li>
</ul>
</li>
</ul>
<h4 id="ways-of-analysing-a-rct-clinical-trial">Ways of Analysing a RCT Clinical Trial<a class="headerlink" href="#ways-of-analysing-a-rct-clinical-trial" title="Permanent link">&para;</a></h4>
<ul>
<li>
<p>Intention-to-treat approach</p>
<ul>
<li>
<p>This is a statistical concept described by Fisher in 1990 to handle problem of major complications in RCT, i.e., noncompliance and missing outcomes</p>
</li>
<li>
<p>ITT analysis includes every subject who is randomized according to randomized treatment assignment. It ignores noncompliance, protocol deviations, withdrawal, and anything that happens after randomization. ITT analysis is usually described as "once randomized, always analyzed".</p>
</li>
<li>
<p>Advantage</p>
<ul>
<li>
<p>ITT analysis avoids overoptimistic estimates of the efficacy of an intervention resulting from the removal of non-compliers by accepting that noncompliance and protocol deviations are likely to occur in actual clinical practice.</p>
</li>
<li>
<p>ITT analysis preserves the sample size because if noncompliant subjects and dropouts are excluded from the final analysis, it might significantly reduce the sample size, leading to reduced statistical power.</p>
</li>
<li>
<p>Moreover, subjects may be noncompliant or may drop out from the study due to their response of treatment.</p>
</li>
<li>
<p>Reduces Type I error</p>
</li>
</ul>
</li>
<li>
<p>Cons</p>
<ul>
<li>
<p>estimate of treatment effect is generally conservative because of dilution due to noncompliance.</p>
</li>
<li>
<p>Also, heterogeneity might be introduced if noncompliants, dropouts and compliant subjects are mixed together in the final analysis.</p>
</li>
<li>
<p>Moreover, end-point data will differ markedly among noncompliant, dropouts and compliant subjects, and interpretation might become difficult if a large proportion of participants cross over to opposite treatment arms</p>
</li>
<li>
<p>Subjected to increase Type II error</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Modified intention-to-treat approach</p>
<ul>
<li>
<p>mITT is a subset of the ITT population and allows the exclusion of some randomized subjects in a justified way (such as patients who were deemed ineligible after randomization or certain patients who never started treatment).</p>
</li>
<li>
<p>Definition given to the modified ITT (mITT) in randomized controlled trial has been found to be irregular and arbitrary because there is a lack of consistent guidelines for its application</p>
</li>
<li>
<p>mITT analysis allows a subjective approach in entry criteria, which may lead to confusion, inaccurate results, and bias.</p>
</li>
</ul>
</li>
<li>
<p>Per-protocol (PP) Analysis</p>
<ul>
<li>
<p>Inclusion in the analysis of only those patients who strictly adhered to the protocol.</p>
</li>
<li>
<p>The PP analysis provides an estimate of the true efficacy of an intervention, i.e., among those who completed the treatment as planned. However, as discussed above, its results do not represent the real life situation and it is likely to show an exaggerated treatment effec</p>
</li>
</ul>
</li>
</ul>
<h4 id="statistical-measures">Statistical measures<a class="headerlink" href="#statistical-measures" title="Permanent link">&para;</a></h4>
<ul>
<li>
<p>Kaplan-Meier Analysis:</p>
<ul>
<li>
<p>non-parametric statistic used to estimate the survival function from lifetime data.</p>
</li>
<li>
<p>Let <span><span class="MathJax_Preview">\tau \geq 0</span><script type="math/tex">\tau \geq 0</script></span>be a random variable, which we think of as the time until an event of interest takes place, survival function is defined as <span><span class="MathJax_Preview">S(t) = p(\tau&gt;t)</span><script type="math/tex">S(t) = p(\tau>t)</script></span>, where <span><span class="MathJax_Preview">t = 0 , 1, \dots</span><script type="math/tex">t = 0 , 1, \dots</script></span></p>
</li>
</ul>
</li>
<li>
<p>Harzard Ratio based on Cox Regression Analyses</p>
</li>
</ul>
<h3 id="examining-covid19-through-a-multidimensional-lens">Examining COVID19 - Through a Multidimensional Lens<a class="headerlink" href="#examining-covid19-through-a-multidimensional-lens" title="Permanent link">&para;</a></h3>
<h4 id="covid19-in-the-context-of-emerging-zoonoic-bat-viruses-in-a-quarter-of-century">COVID19 in the context of emerging Zoonoic Bat Viruses in a Quarter of Century<a class="headerlink" href="#covid19-in-the-context-of-emerging-zoonoic-bat-viruses-in-a-quarter-of-century" title="Permanent link">&para;</a></h4>
<p>Prof Wang Linfa\
Founding director of Programme in Emerging Infectious Disease at Duke-NUS\
SingHealth Global Health Institute\</p>
<ul>
<li>
<p>It will not be the first and will not be the last EZBV outbreak</p>
<ul>
<li>
<p>Hendra is 25 years</p>
</li>
<li>
<p>Hendra-Autralia, Nipah-Malaysia, SARS-China, MERS-Saudia Arabia, Ebola-Guinea, COVID-19-China</p>
</li>
</ul>
</li>
<li>
<p>COVID19 is very different from SARS</p>
<ul>
<li>
<p>No, majority of patients (80%) present mild disease, not Severe Acute Respiratory Syndrome</p>
</li>
<li>
<p>But the virus is 80% identical genetically to SARS-CoV</p>
</li>
<li>
<p>Virus taxonomy - 4 levels - family, genus, and species, strain (same species as SARS)</p>
</li>
</ul>
</li>
<li>
<p>5 levels of up response</p>
</li>
<li>
<p>Genetic stability</p>
<ul>
<li>
<p>Genetically stable - good for vacine and diagnostics development; bad because it will maintain the transmission/case fatality</p>
</li>
<li>
<p>There is now a mutation</p>
</li>
</ul>
</li>
<li>
<p>Role of serology</p>
<ul>
<li>
<p>PCR is more sensitive and precise but narrow window</p>
</li>
<li>
<p>Serology is more specific and longer window</p>
</li>
</ul>
</li>
<li>
<p>Application</p>
<ul>
<li>
<p>Koch's postulates: when there is an infectious disease outbreak, a while before you can claim before it is a new disease;</p>
</li>
<li>
<p>Double edge sword of social media - good for spreading information, but also cause panic and misinformation</p>
</li>
<li>
<p>It's not bats' fault</p>
</li>
<li>
<p>Work for war time has to be done in peace time</p>
</li>
</ul>
</li>
</ul>
<h4 id="exploring-the-use-of-modelling-to-evaluate-policy-response-to-covid19">Exploring the Use of Modelling to Evaluate Policy Response to COVID19<a class="headerlink" href="#exploring-the-use-of-modelling-to-evaluate-policy-response-to-covid19" title="Permanent link">&para;</a></h4>
<p>A/Prof John Ansah\
Health Service and Systems Research in Duke-NUS\
SingHealth Global Health Institute\</p>
<ul>
<li>
<p>Models</p>
<ul>
<li>
<p>Synthesizing the best available data</p>
</li>
<li>
<p>Identifying important areas of uncertainty that may be prioritized for urgent research e.g. what predicts mortality, what's contributing to the spread of disease</p>
</li>
<li>
<p>Comparing control and mitigation strategies to see how these impact incidence, prevalence, outcome etc.</p>
</li>
</ul>
</li>
<li>
<p>Current strategies</p>
<ul>
<li>
<p>Contract tracing and qurantine/isolation</p>
</li>
<li>
<p>Social distancing: limit large gathering</p>
</li>
<li>
<p>Vaccination</p>
</li>
<li>
<p>School closure</p>
</li>
<li>
<p>Risk communication</p>
</li>
<li>
<p>Travel ban</p>
</li>
</ul>
</li>
<li>
<p>Methods</p>
<ul>
<li>
<p>He uses system dynamics - stock and flow model!</p>
</li>
<li>
<p>Develop a mental model of the diease</p>
</li>
<li>
<p>Identify where are the strategies that's applied</p>
</li>
<li>
<p>Show the confirmed cases in worst-case, bsae-case, best-case</p>
</li>
<li>
<p>Infection outcomes and healthcare outcomes</p>
</li>
</ul>
</li>
<li>
<p>In Singapore, assume best case</p>
<ul>
<li>
<p>Contact tracing - 4 days: 90% contact tracing vs 100% contact tracing - not too much of a difference</p>
</li>
<li>
<p>Reduction is significant with faster contact tracing</p>
</li>
<li>
<p>87 ICU beds only</p>
</li>
</ul>
</li>
<li>
<p>What is the relative importance of the different strategies</p>
</li>
</ul>
<h4 id="deploying-digital-technology-for-covid19">Deploying Digital Technology for COVID19<a class="headerlink" href="#deploying-digital-technology-for-covid19" title="Permanent link">&para;</a></h4>
<p>Prof Wong Tien Yin\
Vice Dean Duke-NUS\
Deputy CEO Research and Technology SingHealth\</p>
<ul>
<li>
<p>non-digital methods</p>
<ul>
<li>
<p>Telepresence robots</p>
</li>
<li>
<p>Medical drones</p>
</li>
<li>
<p>Novel laboratory techniques</p>
</li>
</ul>
</li>
<li>
<p>Digital health technology: for Monitoring, surveillance, detection, and prevention of COVID19, as well as mitigation of impact</p>
<ul>
<li>
<p>Digital platform for data</p>
</li>
<li>
<p>Digital platforms for communication</p>
</li>
<li>
<p>Internet of things:</p>
<ul>
<li>
<p>Real-time tracking and live updates in various online databases in US, UK, and China</p>
</li>
<li>
<p>Live-tracking of the at-risk vincity in Korea</p>
</li>
<li>
<p>Virtual clinics</p>
</li>
<li>
<p>Public information dissemination via WhatsApp in Singapore</p>
</li>
</ul>
</li>
<li>
<p>Big data</p>
<ul>
<li>
<p>modelling disease activity</p>
</li>
<li>
<p>potential growth and areas of spread</p>
</li>
<li>
<p>Modeling of the preparedness</p>
</li>
<li>
<p>HangZhou Health stratification</p>
</li>
</ul>
</li>
<li>
<p>Artificial Intelligence (AI)</p>
<ul>
<li>real time analytics of big data to inform decisions</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Problems</p>
<ul>
<li>
<p>How do we get data?</p>
</li>
<li>
<p>Online screener</p>
</li>
<li>
<p>Risk stratify</p>
</li>
<li>
<p>How to go forward? Cloud-based referral platform / digital consultation</p>
</li>
</ul>
</li>
<li>
<p>A unique opportunity for digital technology, public and patients' acceptance might improve during infectious disease;</p>
</li>
<li>
<p>Good publication opportunity - digital health in ID</p>
</li>
</ul>
<h4 id="issues-in-coordinating-a-global-response">Issues in Coordinating a Global Response<a class="headerlink" href="#issues-in-coordinating-a-global-response" title="Permanent link">&para;</a></h4>
<p>Prof John Lim\
Singhealth Duke-NUS Global Health Insitute\
Center for Regulatory Excellence\</p>
<ul>
<li>
<p>Current gaps in global coordination and response mobilization include</p>
<ul>
<li>
<p>Diverse local and global players</p>
</li>
<li>
<p>Timely disease detection</p>
</li>
<li>
<p>Availability of basic care</p>
</li>
<li>
<p>Contact tracing, quanrantine, and isolation procedure</p>
</li>
<li>
<p>Preparedness outside health sector</p>
</li>
</ul>
</li>
<li>
<p>Mobilization and distribution of resoures to countries and vested partners is critical - fall out from resource limited countries even in developed world, can negate positive efforts</p>
</li>
<li>
<p>Securing and maintaining commitment of governments and vested partners - once current threat is over, attention is lost</p>
</li>
<li>
<p>WHO does not have sufficient influence over local and national juristication</p>
</li>
<li>
<p>International Health Regulations allow WHO to work with countries to investigate outbreaks, assess risk, and facilitate timely declaration of outbreak status; but activation of WHO is slow</p>
</li>
<li>
<p>Coalition for Epidemic Preparedness INnovations (CEPI) set up at 2017 World Economic Forum following Ebola</p>
<ul>
<li>
<p>Worried about antibody-dependent enhancement</p>
</li>
<li>
<p>Risks due to ongoing parallel research not building on previous finings</p>
</li>
</ul>
<p><code>{=html}
&lt;!-- --&gt;</code>
-   Investment in prevention and preparation</p>
<ul>
<li>
<p>Esstblish clear mechnaism for coordaintion and escalation</p>
</li>
<li>
<p>Engage counications</p>
</li>
<li>
<p>Promote harmonization</p>
</li>
</ul>
</li>
</ul>
<h4 id="gauging-the-economics-and-market-implications-of-covid19">Gauging the Economics and Market Implications of COVID19<a class="headerlink" href="#gauging-the-economics-and-market-implications-of-covid19" title="Permanent link">&para;</a></h4>
<p>Dr Taimur Baig\
Managing Director and Chief Economist, DBS Bank\</p>
<ul>
<li>
<p>Thesis: Financial market contagion</p>
</li>
<li>
<p>Summary of contagion is Fatality Rate vs Ro</p>
</li>
<li>
<p>Impression is that Ro is the function of behavior, policy, and treatment <span><span class="MathJax_Preview">\text{Ro} = f(b, k, d)</span><script type="math/tex">\text{Ro} = f(b, k, d)</script></span> However, there is a huge heterogenity in global responses; this has undermined market confidence</p>
</li>
<li>
<p>Considerable uncertainty and senst of vulnerability</p>
<ul>
<li>
<p>When will this end?</p>
</li>
<li>
<p>How will this end?</p>
</li>
<li>
<p>What will be the damage?</p>
</li>
<li>
<p>Are asymptomatic carriers infectious?</p>
</li>
</ul>
</li>
<li>
<p>Downside risk galore</p>
<ul>
<li>
<p>Supply shock - we will see this as a rippling effect in the coming months; even when China goes back to work, it will take time for things to come back to normal</p>
</li>
<li>
<p>Demand shock - travel and transportation shutdown; the world is largely service industry driven; we cannot make up for service sector cesassion of activity.</p>
</li>
<li>
<p>Shortages</p>
</li>
<li>
<p>Credit risk</p>
</li>
<li>
<p>Limited policy efficacy</p>
</li>
</ul>
</li>
</ul>
<h4 id="converging-the-discourses-on-covid19">Converging the Discourses on COVID19<a class="headerlink" href="#converging-the-discourses-on-covid19" title="Permanent link">&para;</a></h4>
<ul>
<li>
<p>Read how serology was used to enable tracing</p>
</li>
<li>
<p>How are we able to mobilize the Apple to do this</p>
</li>
<li>
<p>Online screener - what does it take to develop?</p>
</li>
<li>
<p>How do you accelerate the development of these tools?</p>
</li>
<li>
<p>Prof Wong - as the virus evolve, how does that impact the testing and vaccine development?</p>
</li>
<li>
<p>Dr Baig - business world worried about? How long would it take for us to recover? Would this impact research funding in the future? Prof Ansah, can we use system dynamics to model the economic effect? and global oscillation; Prof Wong - technolgoies reach patients fast? Online screener easy to implement? Prof Lim -</p>
</li>
<li>
<p>Impact on medical tourism</p>
</li>
<li>
<p>Market underwhelmed - 700 - 800 billion governemnt; 1 - 2 years for recovery; money thrown at what? how long are we going to have no movies and no going to restaurants?</p>
</li>
<li>
<p>How to prevent this in the future?</p>
</li>
</ul>
<p><code>{=html}
&lt;!-- --&gt;</code>
-   States is working on mitigation as opposed to containment</p>
<ul>
<li></li>
</ul>
<h3 id="nsrl-p01-meetings-multi-scale-anesthesiology-reesarch">NSRL P01 Meetings - Multi-scale Anesthesiology Reesarch<a class="headerlink" href="#nsrl-p01-meetings-multi-scale-anesthesiology-reesarch" title="Permanent link">&para;</a></h3>
<h4 id="general">General<a class="headerlink" href="#general" title="Permanent link">&para;</a></h4>
<p>Principles of Pharmacological Research</p>
<ul>
<li>
<p>Dose dependent effects are important to account for in pharmacological research. This may not just be about the intensification of one type of effect but onset of / switching between rather different effects.</p>
<ul>
<li>ketamine - high - 1.67 mg/kg/min</li>
</ul>
</li>
<li>
<p>Bolus and continuous infusion has different dynamics / effects.</p>
</li>
</ul>
<h4 id="human">Human<a class="headerlink" href="#human" title="Permanent link">&para;</a></h4>
<p>Propofol</p>
<ul>
<li>
<p>Globally coherent frontal alpha oscillations</p>
</li>
<li>
<p>Globally incoherent slow-delta oscillations</p>
</li>
<li>
<p>PCA slow delta oscillations</p>
</li>
<li>
<p>Loss of frontal parietal functional connectivity</p>
</li>
</ul>
<p>Dex has GABA-ergic effect and at high dose may potentiate GABAergic effects</p>
<h4 id="non-human-primate">Non-human Primate<a class="headerlink" href="#non-human-primate" title="Permanent link">&para;</a></h4>
<p>Jake</p>
<ul>
<li>
<p>Gamma is lower in humnan than primate.</p>
</li>
<li>
<p>Frequency bands are different in different species.</p>
</li>
</ul>
<p>Yumi - recovery of brain from anesthetic induced unconsciousness</p>
<ul>
<li>Maybe prediction of ROC is more important than LOC because ROC is more variable.</li>
</ul>
<h4 id="rodents">Rodents<a class="headerlink" href="#rodents" title="Permanent link">&para;</a></h4>
<p>Jen (2018 Feb 9)</p>
<ul>
<li>
<p>Propofol, dex, ketamine given to rats and induced distinct PFC LFP signatures that have in common high-amplitude delta oscillations</p>
</li>
<li>
<p>Propofol in paradoxical excitation has beta-gamma;</p>
</li>
<li>
<p>Slow oscillations have sharp peaks</p>
</li>
<li>
<p>Morlet wavelet analysis and period selection with PCA and k-means clustering asking for 2 states for capture of distinct oscillatory states. Just looking for an objective way of pulling out the states.</p>
</li>
<li>
<p>Onset of prefrontal delta and alpha-beta oscillations correlates with loss of EMG tone under propofol anesthesia, consistent with Purdon et al 2013, and Flores et al 2017. Alpha-beta oscillations dominate after loss of EMG tone.</p>
</li>
<li>
<p>Template spectrum for classification</p>
</li>
</ul>
<p>Eric Microinjection</p>
<ul>
<li>
<p>picrotoxin is a GABA antagonist used in research due to high toxicity as a CNS and respiratory system stimulant</p>
</li>
<li>
<p>microinjection of picrotoxin at PFC</p>
</li>
</ul>
<p>Francisco</p>
<ul>
<li>
<p>Multi-electrode arrays record multiple single unit activity and local field potentials from one or more brain regions during and after anestheic dosing</p>
</li>
<li>
<p>Note that we can re-establish the LORR with EEG recording to establish the LOPWM.</p>
</li>
</ul>
<h4 id="modeling">Modeling<a class="headerlink" href="#modeling" title="Permanent link">&para;</a></h4>
<h4 id="data-core">Data Core<a class="headerlink" href="#data-core" title="Permanent link">&para;</a></h4>
                
                  
                    

<hr>
<div class="md-source-date">
  <small>
    
      Last update: April 7, 2020
    
  </small>
</div>
                  
                
              
              
                


              
            </article>
          </div>
        </div>
      </main>
      
        
<footer class="md-footer">
  
    <div class="md-footer-nav">
      <nav class="md-footer-nav__inner md-grid" aria-label="Footer">
        
          <a href="../psychiatry/" title="Psychiatry" class="md-footer-nav__link md-footer-nav__link--prev" rel="prev">
            <div class="md-footer-nav__button md-icon">
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20,11V13H8L13.5,18.5L12.08,19.92L4.16,12L12.08,4.08L13.5,5.5L8,11H20Z" /></svg>
            </div>
            <div class="md-footer-nav__title">
              <div class="md-ellipsis">
                <span class="md-footer-nav__direction">
                  Previous
                </span>
                Psychiatry
              </div>
            </div>
          </a>
        
        
          <a href="../temp-notes/" title="Temporary notes" class="md-footer-nav__link md-footer-nav__link--next" rel="next">
            <div class="md-footer-nav__title">
              <div class="md-ellipsis">
                <span class="md-footer-nav__direction">
                  Next
                </span>
                Temporary notes
              </div>
            </div>
            <div class="md-footer-nav__button md-icon">
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M4,11V13H16L10.5,18.5L11.92,19.92L19.84,12L11.92,4.08L10.5,5.5L16,11H4Z" /></svg>
            </div>
          </a>
        
      </nav>
    </div>
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-footer-copyright">
        
          <div class="md-footer-copyright__highlight">
            Copyright &copy; 2020 Jingzhi An
          </div>
        
        made with
        <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
          Material for MkDocs
        </a>
      </div>
      
  <div class="md-footer-social">
    
      
      
      <a href="https://github.com/jingzhian" target="_blank" rel="noopener" title="github.com" class="md-footer-social__link">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 480 512"><path d="M186.1 328.7c0 20.9-10.9 55.1-36.7 55.1s-36.7-34.2-36.7-55.1 10.9-55.1 36.7-55.1 36.7 34.2 36.7 55.1zM480 278.2c0 31.9-3.2 65.7-17.5 95-37.9 76.6-142.1 74.8-216.7 74.8-75.8 0-186.2 2.7-225.6-74.8-14.6-29-20.2-63.1-20.2-95 0-41.9 13.9-81.5 41.5-113.6-5.2-15.8-7.7-32.4-7.7-48.8 0-21.5 4.9-32.3 14.6-51.8 45.3 0 74.3 9 108.8 36 29-6.9 58.8-10 88.7-10 27 0 54.2 2.9 80.4 9.2 34-26.7 63-35.2 107.8-35.2 9.8 19.5 14.6 30.3 14.6 51.8 0 16.4-2.6 32.7-7.7 48.2 27.5 32.4 39 72.3 39 114.2zm-64.3 50.5c0-43.9-26.7-82.6-73.5-82.6-18.9 0-37 3.4-56 6-14.9 2.3-29.8 3.2-45.1 3.2-15.2 0-30.1-.9-45.1-3.2-18.7-2.6-37-6-56-6-46.8 0-73.5 38.7-73.5 82.6 0 87.8 80.4 101.3 150.4 101.3h48.2c70.3 0 150.6-13.4 150.6-101.3zm-82.6-55.1c-25.8 0-36.7 34.2-36.7 55.1s10.9 55.1 36.7 55.1 36.7-34.2 36.7-55.1-10.9-55.1-36.7-55.1z"/></svg>
      </a>
    
      
      
      <a href="https://twitter.com/drdrjzan" target="_blank" rel="noopener" title="twitter.com" class="md-footer-social__link">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg>
      </a>
    
      
      
      <a href="https://linkedin.com/in/jingzhi-an-281a9315" target="_blank" rel="noopener" title="linkedin.com" class="md-footer-social__link">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"/></svg>
      </a>
    
  </div>

    </div>
  </div>
</footer>
      
    </div>
    
      <script src="../assets/javascripts/vendor.23350dc5.min.js"></script>
      <script src="../assets/javascripts/bundle.36a8f969.min.js"></script><script id="__lang" type="application/json">{"clipboard.copy": "Copy to clipboard", "clipboard.copied": "Copied to clipboard", "search.config.lang": "en", "search.config.pipeline": "trimmer, stopWordFilter", "search.config.separator": "[\\s\\-]+", "search.result.placeholder": "Type to start searching", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents"}</script>
      
      <script>
        app = initialize({
          base: "..",
          features: ["instant", "tabs"],
          search: Object.assign({
            worker: "../assets/javascripts/worker/search.3bc815f0.min.js"
          }, typeof search !== "undefined" && search)
        })
      </script>
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=TeX-MML-AM_CHTML"></script>
      
    
  </body>
</html>